Results for
"[search-keyword]"
Sponsor content
29 result(s) found, displaying 11 to 20
-
Cancellation by sponsorRequested by Biogen Australia Pty Ltd
-
Prescription medicine decision summaryTGA Decision: Vumerity (diroximel fumarate) is approved to treat relapsing multiple sclerosis.
-
Prescription medicine registrationActive ingredients: diroximel fumarate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SPINRAZA nusinersen (as heptadecasodium) 12 mg/ 5 mL solution for injection vial.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Nusinersen (as heptadecasodium)
-
Cancellation by sponsorRequested by Biogen Australia Pty Ltd
-
Cancellation by sponsorRequested by Biogen Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PLEGRIDY peginterferon beta-1a (rch) 63 microgram/0.5 mL and 94 microgram/0.5 mL solution for injection pre-filled syringe TITRATION PACK.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PLEGRIDY peginterferon beta-1a (rch) 125 microgram/0.5 mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PLEGRIDY peginterferon beta-1a (rch) 125 microgram/0.5 mL solution for injection pre-filled pen.